ATKINSON EDWARD MORROW III (EVP, Chief Technical Ops. Off.) sold 3.5% of their position (668.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $324.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0000875320-26-000106
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
-2.29K
Net shares
Net seller
$1.11M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
2.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.63K
Price / share
$485.11
Trade value
$789.27K
% of position
7.8%
2/24/2026
20.73K→19.10K
Common Stock
Direct
Shares
−668.00
Price / share
$486.35
Trade value
$324.88K
% of position
3.5%
2/25/2026
19.10K→18.43K
Total
Net shares
−2.29K
Net value
-$1.11M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −1.63K | $485.11 | $789.27K | 7.8% | 20.73K | 19.10K |
| Common Stock Direct | 2/25/2026 | S · Sale | −668.00 | $486.35 | $324.88K | 3.5% | 19.10K | 18.43K |
| Total | −2.29K | -$1.11M | ||||||
Derivative Transactions0
No derivative transactions reported